Toll-like receptors: lessons to learn from normal and malignant human B cells
about
Sphingosine-1-phosphate suppresses TLR-induced CXCL8 secretion from human T cellsToll-like receptor (TLR)-1/2 triggering of multiple myeloma cells modulates their adhesion to bone marrow stromal cells and enhances bortezomib-induced apoptosisAn in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapySTATs in cancer inflammation and immunity: a leading role for STAT3Toll-like receptors on B-CLL cells: expression and functional consequences of their stimulation.The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors.Macropinocytosis is responsible for the uptake of pathogenic and non-pathogenic mycobacteria by B lymphocytes (Raji cells)Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond.Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus.Characterization of the Toll-like receptor expression profile in human multiple myeloma cells.Pellino 1 promotes lymphomagenesis by deregulating BCL6 polyubiquitination.IRF-4 suppresses BCR/ABL transformation of myeloid cells in a DNA binding-independent manner.Therapeutic Toll-like receptor agonists directly influence mouse and human T cell lymphoma cell viability and cytokine secretionToll-Like Receptor 1/2 and 5 Ligands Enhance the Expression of Cyclin D1 and D3 and Induce Proliferation in Mantle Cell Lymphoma.TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphismIntegrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cellsThe Role of PPARs in Placental Immunology: A Systematic Review of the Literature.Dysregulated B-cell TLR2 expression and elevated regulatory B-cell frequency precede the diagnosis of AIDS-related non-Hodgkin lymphoma.Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect.Distinct Differentiation Programs Triggered by IL-6 and LPS in Teleost IgM(+) B Cells in The Absence of Germinal Centers.Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.Long-term protection from syngeneic acute lymphoblastic leukemia by CpG ODN-mediated stimulation of innate and adaptive immune responses.B7-1/2 (CD80/CD86) direct signaling to B cells enhances IgG secretion.The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity.Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.Toll-like receptors--sentries in the B-cell response.Endogenous toll-like receptor ligands and their biological significance.Toll-like receptor 9 agonists as cancer therapeutics.Exogenous or endogenous Toll-like receptor ligands: which is the MVP in tumorigenesis?Innate immunity and hepatitis C virus infection: a microarray's view.B-lymphocyte lineage cells and the respiratory system.Toll-like receptors in the pathogenesis of human B cell malignancies.The role of toll-like receptors in B-cell development and immunopathogenesis of common variable immunodeficiency.Synergy of interleukin 10 and toll-like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis.Toll-like receptors targeting technology for the treatment of lymphoma.What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis?Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice.Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells.Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas
P2860
Q28284022-7AEC9753-909D-494F-A084-FEF35220AD73Q28538422-AE6A7EF1-7D09-4E61-BCFF-FF52FBAE0A31Q28729093-A59C0877-1EBB-40EB-AA61-B8D6444DD2ACQ29547203-63F0A083-A5C8-4BB0-8262-C448397D7267Q33494116-3BB4FB97-301C-4D6C-AA20-B9FD8E352441Q34021580-572F207E-CFAD-4545-9404-71678BACE097Q34154994-C848E91F-FA07-48DF-9613-5167E667C8C8Q34462647-B9B9354B-93BE-4CD4-B0E4-8B1AA948518FQ34495557-CDC77336-6533-45C8-B2D5-105E39338D9AQ34602046-D9D1FEFA-6C4A-45C4-BD3F-C2B9925D53A6Q34673706-FDDF9521-DFD8-454A-A48B-5A3F4A2D92B1Q35140039-D2970104-2509-40C3-A1BD-68051C45752AQ35693948-81469269-ACBC-42E3-BD16-858C136119B8Q35920787-784A4171-951B-4AB4-A627-8974C9EB8958Q36001708-9068425C-28F5-4AF1-B861-98DB93BA8C33Q36071989-A32D2E9C-5A9D-4602-AF93-757F929D528BQ36271580-74E67A84-B4D8-48C4-AF24-A2FB65F2286CQ36716822-F9490EAB-9DFE-41A2-85A7-0C3502C06BFFQ36781293-DF3330F7-45BC-4B33-9B5B-5992C5F0E4FAQ37053088-B3F39655-FAEA-442A-AFD6-A9D1FEF3EC31Q37144548-58CEF13F-325E-48F4-A331-45A446DC4581Q37318226-233D874C-901F-4981-8EA0-54372B8C8B95Q37352480-19B292CC-A2A5-4DC5-ADF2-5E0DB85E9D3AQ37480851-D758535C-A769-4BE9-9605-69FE4A27A5F1Q37583889-9772181A-131B-46DD-A31B-F7E2C95A2550Q37671216-F08FC6AA-D9DA-4C12-B601-A41C5BFA21EFQ37672658-827BA114-8863-44C3-9934-4421073D414CQ37772578-B270D628-7F62-42BA-B5A1-716B80686D8EQ37831323-8FCA0696-0E7A-4111-9E2C-968BEB87BB98Q37952071-A1DC3EC4-BD97-4020-80B4-216A01143E9FQ37997024-36EE0EE6-536C-449C-8A4E-ADF8F52573D1Q38094250-12FFA921-7090-40DE-B6E2-777C00C3ED57Q38238963-D6DECE6F-F3E1-4141-88D6-AFA2FD0D1C85Q38665495-31F7EBAE-D6DA-49D3-9F45-8A89F9835688Q38743752-13841418-22E6-474B-A7BE-C8ABD33EA03CQ38948266-8F2E852C-21F7-45E1-AFBF-2814F2F6F728Q40273988-AA406620-BE7B-4495-BB01-05040383D100Q41786115-28C940DB-651C-4C51-B474-2DD68F0E3CF0Q41876189-9F184273-1E4D-42CF-A775-01B38E595D73Q42005623-C2084D56-4666-4225-ABA8-CD5482CCD9A0
P2860
Toll-like receptors: lessons to learn from normal and malignant human B cells
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Toll-like receptors: lessons to learn from normal and malignant human B cells
@en
Toll-like receptors: lessons to learn from normal and malignant human B cells.
@nl
type
label
Toll-like receptors: lessons to learn from normal and malignant human B cells
@en
Toll-like receptors: lessons to learn from normal and malignant human B cells.
@nl
prefLabel
Toll-like receptors: lessons to learn from normal and malignant human B cells
@en
Toll-like receptors: lessons to learn from normal and malignant human B cells.
@nl
P2093
P2860
P1433
P1476
Toll-like receptors: lessons to learn from normal and malignant human B cells
@en
P2093
Catherine Pellat-Deceunynck
David Chiron
Gaëtan Jego
Isabelle Bekeredjian-Ding
Régis Bataille
P2860
P304
P356
10.1182/BLOOD-2008-02-140673
P407
P577
2008-06-30T00:00:00Z